SEGMENT REPORTING (Details) $ in Thousands |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2024
USD ($)
segment
|
Dec. 31, 2023
USD ($)
|
|
| Segment Reporting Information [Line Items] | ||
| Number of reportable segments | segment | 1 | |
| Interest income | $ (5,042) | $ (5,945) |
| Consolidated net loss | 69,628 | 75,521 |
| Life Science | ||
| Segment Reporting Information [Line Items] | ||
| AV-101 clinical trials | 19,740 | 26,548 |
| Employee costs | 19,512 | 21,244 |
| Professional fees and services | 11,482 | 6,289 |
| Stock-based compensation | 11,311 | 11,907 |
| Chemistry, manufacturing, and controls | 11,110 | 14,339 |
| Other segment items | 1,515 | 1,139 |
| Interest income | $ (5,042) | $ (5,945) |
| X | ||||||||||
- Definition Amount of expense associated with the AV-101 clinical trials. No definition available.
|
| X | ||||||||||
- Definition Expenses associated with chemistry, manufacturing and controls. No definition available.
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). No definition available.
|
| X | ||||||||||
- Definition The amount of stock-based compensation. No definition available.
|
| X | ||||||||||
- Definition The net amount of nonoperating interest income (expense). No definition available.
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|